Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Monday November 16, 2009

DrStockPick.com Stock Report!

**************************************************************

PowerSafe Technology Corporation (PSFT.PK) subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com) (ATI), is offering higher performance thermoelectrically cooled discrete amplification single photon counting solid state photodetectors. These photodetectors are mounted on a two stage thermoelectric cooler inside a hermetically sealed TO8 package and can be operated down to a temperature of -30oC.

For an unprecedented fifth year in a row, readers of Business Insurance once again have named CIGNA’s Employee Assistance Program (EAP) the best in the industry.

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday October 23, 2009

DrStockPick.com Stock Report!

**************************************************************

Consorteum Holdings Inc. (OTCBB: CSRH) announced that it has signed a Letter of Intent with Tactical Connections Inc. to provide various financial services to major tier one US, Canadian and European manufacturing and retail industries.

Builders FirstSource, Inc. (Nasdaq:BLDR), a leading supplier and manufacturer of structural and related building products for residential new construction in the United States, today announced a $205 million common stock rights offering and debt exchange for its outstanding Second Priority Senior Secured Floating

Formerly known as Ophthalmic Technologies Inc. Opko Health has recently agreed to acquire Chilean pharmaceutical company named Pharma Genexx for around US$ 16 million in cash. One of the reasons why this Florida-based pharma giant is taking up Chilean pharmaceutical is to enter the emerging markets in the future. The Miami-based Opko Health is a specialty healthcare company that is currently involved in the discovery, development and commercialization of pharmaceutical products, vaccines and diagnostic technologies. However, with this acquisition Opko Health is looking to expand into new areas like oncology and neurological disorders.

Opko Health CEO and Chairman Philip Frost have said that Opko Health believes that this acquisition will be an excellent strategic fit for Opko to expand further into international market. Currently, Pharma Genexx is involved in the representation,

An unexpected drop in consumer confidence sent U.S. stocks lower Tuesday, as signs of stabilization in housing and Walgreen’s solid earnings failed to convince investors about the strength of an economic recovery.  Although stocks rose slightly after the opening bell, the early morning release of the confidence report took the Street by surprise and signaled the American consumers are not as hopeful about an economic turnaround.

Stocks swung between gains and losses and volume remained light.  Treasury prices declined, with the 10-year off 4/32 and the corresponding yield rising to 3.293%.  The Dow Jones industrial average lost 47 points, or 0.5%. The S&P 500 index lost 2 points, or 0.2%. The tech-heavy Nasdaq composite retreated 2 points, or 0.2%.  On the New York Stock Exchange, 1.18 billion shares exchanged hands with losers narrowly ahead of winners.

The greenback showed modest gains against a basket of currencies, closing at its

Biovail Corporation (NYSE:BVF) August 24, 2009 announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera’s JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson’s Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD), the largest drugstore chain in China based on the number of directly operated stores, August 24, 2009 announced the resignation of Mr. Jiannong Qian as the Company’s Co-Chief Executive Officer and a director of the Board, effective on August 20, 2009, upon the expiration of Mr. Qian’s employment agreement with the Company. Mr. Qian intends to pursue other opportunities. Upon Mr. Qian’s resignation, Mr. Ian Wade, who had

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Monday August 24, 2009

PennyOmega.com Stock Report!

**************************************************************

Biovail Corporation (NYSE:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera’s JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson’s Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.

Cell Therapeutics, Inc. (Nasdaq: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company’s New

DrStockPick.com Stock Report!

Wednesday August 5, 2009

**************************************************************

The Procter & Gamble Company (NYSE:PG) announced diluted net earnings per share for the fiscal year ending June 30, 2009 of $4.26, up 17 percent and exceeding the Company’s guidance range of $4.20 to $4.25. Core EPS, which excludes the current year impact from the sale of the Folgers business and certain tax adjustments in the prior fiscal year, increased eight percent versus fiscal 2008. For the April - June quarter, diluted net earnings per share were $0.80, above the Company’s guidance range of $0.74 to $0.79 for the quarter.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD), the largest drugstore chain in China based on the number

Let’s just ignore that GAP (GPS) said when the board committee first launched its search it said that it intended to find an apparel merchant with “deep” experience in retail and merchandising.